Question 1

What is Vyne Therapeutics Inc (VYNE) stock price today?

Accepted Answer

Vyne Therapeutics Inc (VYNE) currently trades at $0.67 per share. The stock has a market capitalization of $21.39M and a P/E ratio of —x.

Question 2

Is VYNE stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Vyne Therapeutics Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Vyne Therapeutics Inc's revenue and earnings?

Accepted Answer

Vyne Therapeutics Inc has trailing twelve-month (TTM) revenue of $570000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.63.

Question 4

Is VYNE stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Vyne Therapeutics Inc's intrinsic value is $0.87, representing a margin of safety of 35.98%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$477000.00	$424000.00	$501000.00	$570000.00	$570000.00
Net income	$-23.21M	$-28.45M	$-39.83M	$-26.48M	$-4.84M
EPS	—	—	—	—	$-0.63
Free cash flow	$-29.20M	$-25.34M	$-34.09M	$-33.12M	$-3.76M
Profit margin	-4,865.83%	-6,710.38%	-7,950.90%	-4,646.14%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VYNE	$21.39M	34	6.7	2.5	6.7	5.0	+35.98%	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Vyne Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

Stock snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare